Literature DB >> 8374893

Fanconi anemia. Chromosome breakage and cell cycle studies.

R Berger1, M Le Coniat, M C Gendron.   

Abstract

The experience with cytogenetic and flow cytometry methods used for the diagnosis of Fanconi anemia (FA) in one center is summarized. The tests consist of chromosomal breakage and cell cycle studied after sensitization by the introduction of nitrogen mustard into phytohemagglutinin-stimulated blood-cell cultures. The cytogenetic test was shown to be reliable in ascertaining the diagnosis of FA. Flow cytometry studies showed a marked increase in the percentage of cells in G2/M phase in FA patients after sensitization by nitrogen mustard. This increase, however, could not be detected in three FA patients with myelodysplasia or acute leukemia and the results were ambiguous on three occasions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8374893     DOI: 10.1016/0165-4608(93)90104-t

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

Review 1.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

Review 2.  Topics in pediatric leukemia--Fanconi's anemia: new insights.

Authors:  Noah Federman; Kathleen M Sakamoto
Journal:  MedGenMed       Date:  2005-04-06

3.  Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.

Authors:  Reinhard Kalb; Kornelia Neveling; Holger Hoehn; Hildegard Schneider; Yvonne Linka; Sat Dev Batish; Curtis Hunt; Marianne Berwick; Elsa Callen; Jordi Surralles; Jose A Casado; Juan Bueren; Angeles Dasi; Jean Soulier; Eliane Gluckman; C Michel Zwaan; Rosalina van Spaendonk; Gerard Pals; Johan P de Winter; Hans Joenje; Markus Grompe; Arleen D Auerbach; Helmut Hanenberg; Detlev Schindler
Journal:  Am J Hum Genet       Date:  2007-04-06       Impact factor: 11.025

Review 4.  Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair.

Authors:  Jasmine D Peake; Eishi Noguchi
Journal:  Hum Genet       Date:  2022-05-21       Impact factor: 5.881

Review 5.  Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights.

Authors:  Larry H Thompson; John M Hinz
Journal:  Mutat Res       Date:  2009-02-21       Impact factor: 2.433

6.  Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.

Authors:  C E Walsh; A W Nienhuis; R J Samulski; M G Brown; J L Miller; N S Young; J M Liu
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

7.  An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation.

Authors:  William Marion; Steffen Boettcher; Sonya Ruiz-Torres; Edroaldo Lummertz da Rocha; Vanessa Lundin; Vivian Morris; Stephanie Chou; Anna M Zhao; Caroline Kubaczka; Olivia Aumais; Yosra Zhang; Akiko Shimamura; Thorsten M Schlaeger; Trista E North; Benjamin L Ebert; Susanne I Wells; George Q Daley; R Grant Rowe
Journal:  Blood Adv       Date:  2020-10-13

8.  Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.

Authors:  Chiraz Bouchlaka; Sonia Abdelhak; Ahlem Amouri; Hela Ben Abid; Sondes Hadiji; Mounir Frikha; Tarek Ben Othman; Fethi Amri; Hammadi Ayadi; Mongia Hachicha; Ahmed Rebaï; Ali Saad; Koussay Dellagi
Journal:  J Hum Genet       Date:  2003-06-24       Impact factor: 3.172

9.  Evaluation of concentration and storage effects of mitomycin C in the diagnosis of Fanconi anemia among idiopatic aplastic anemia patients.

Authors:  H Mozdarani; K Abed Ashtiani; A Mohseni-Meybodi
Journal:  Indian J Hum Genet       Date:  2011-09

10.  Role of p53 codon 72 polymorphism in chromosomal aberrations and mitotic index in patients with chronic hepatitis B.

Authors:  H Akbaş; K Yalcin; H Isi; S Tekes; A E Atay; Z Akkus; T Budak
Journal:  Braz J Med Biol Res       Date:  2012-08-16       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.